Mucosal infection and vaccination against feline immunodeficiency virus

Journal of Biotechnology

Volumn 73, Issue 2-3, 1999, Pages 213-221

  Stokes, C R ^a   Finerty, S ^a   Gruffydd Jones, T J ^a   Sturgess, C P ^a   Harbour, D A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Feline immunodeficiency virus; Mucosal infection; Vaccination

Indexed keywords

ANTIBODIES; ANTIGENS; BIOLOGICAL MEMBRANES; CELLS; DNA; GASTROENTEROLOGY; IMMUNIZATION; RNA;

FELINE IMMUNODEFICIENCY VIRUS; MUCOSAL INFECTION; VACCINATION;

VIRUSES;

BIOTIN; CHOLERA TOXIN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; PEROXIDASE; QUIL A; STREPTAVIDIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA; VIRUS VACCINE;

ANIMAL MODEL; BITE; CAT; CONFERENCE PAPER; CYTOTOXIC LYMPHOCYTE; DRUG TARGETING; EPITHELIUM CELL; FELINE IMMUNODEFICIENCY VIRUS; GASTROINTESTINAL MUCOSA; INTRANASAL DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LAMINA PROPRIA; LYMPH FOLLICLE; LYMPH NODE; MUCOSA; NONHUMAN; PARENTERAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; RECTUM MUCOSA; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION; VAGINA MUCOSA; VIRUS CORE; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; BIOTECHNOLOGY; CATS; CYTOKINES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNODEFICIENCY VIRUS, FELINE; MUCOUS MEMBRANE; VIRAL VACCINES;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS;

EID: 0345493202     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1656(99)00139-X     Document Type: Conference Paper

References (40)

1. Amerongen H.M., Weltzin R., Farnet C.M., Michetti P., Haseltine W.A., Neytra M.R. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J. Acquir. Immun. Defic. Synd. 4:1991;760-765.
2. Beatty J.A., Willett B.J., Gault E.A., Jarrett O. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol. 70:1996;6199-6206.
3. Bishop S.A., Stokes C.R., Gruffydd-Jones T.J., Whiting C.V., Harbour D.A. Vaginal and rectal infection of cats with feline immunodeficiency virus. Vet. Microbiol. 51:1996;217-227.
4. Boirivant M., Fuss I., Fiocchi C., Kleins S., Strong S.A., Strober W. Hypoproliferative human lamina propria T-cells retain their capacity to secrete lymphokines when stimulated via CD2/CD28 pathways. Proc. Assoc. Am. Physicians. 108:1996;55-67.
5. Clerici M., Shearer G.M. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:1993;107-111.
6. Couedel-Courteille A., Le Grand R., Tulliez M., Guillet J.-G., Venet A. Direct ex vivo simian immunodeficiency virus (SIV)-specific cytotoxic activity detected from small intestine intraepithelial lymphocytes of SIV-infected macaques at an advanced stage of infection. J. Virol. 71:1997;1052-1057.
7. + T-lymphocytes of African green monkeys secrete an immunodeficiency virus suppressing factors. Proc. Natl. Acad. Sci. 91:1994;7207-7211.
8. Fantini J., Yahi N., Delezay O., Gonzalez-Scarano F. GalCer, CD26 and HIV infection of intestinal epithelial cells. AIDS. 8:1994;1347-1348.
9. Flynn J.N., Keating P., Hosie M.J., Macket M., Stephen E.B., Beatty J.A., Neil J.C., Jarrett O. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination. J. Immunol. 157:1996;3658-3665.
10. Hazama M., Mayumi-Aono A., Miyazaki T., Hinuma S., Fujisawa Y. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the β subunit of Escherichia coli heat labile enterotoxin and interleukin. Immunology. 78:1993;643-649.
11. Hosie M.J., Flynn J.N. Feline immunodeficiency virus vaccination: characterisation of the immune correlation of protection. J. Virol. 70:1996;7561-7568.
12. Husband A.J., Kramer D.R., Bao S., Sutherland R.M., Beagley K.W. Regulation of mucosal IgA responses in vivo: cytokines and adjuvants. Vet. Immunol. Immunopathol. 54:1996;179-186.
13. Hussain L.A., Lehner T. Comparative investigation of Langerhans cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology. 85:1995;475-484.
14. Jullien D., Sieling P.A., Uyemura K., Mar N.D., Rea T.H., Modlin R.L. IL-15 an immunomodulator of T cell responses in intracellular infection. J. Immunol. 158:1997;800-806.
15. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., Boyer J.D., Weiner D.B. In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
16. Klavinskis L.S., Bergmeier L.A., Gao L., Mitchell E., Ward R.G., Layton G., Brookes R., Meyers N.J., Lehner T. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J. Immunol. 157:1996;2521-2527.
17. Koup R.A., Safrit J.T., Cao Y., Andrews Ca., Mcleod G., Borkowsky W., Farthing C., Ho D.D. Temporal associates of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type-1 syndrome. J. Virol. 68:1994;4650-4655.
18. + T-cell phenotype correlates with anti-HIV activity and asymptomatic clinical states. Clin. Immunol. Immunopathol. 69:1993;106-116.
19. Lehner T., Wang Y.F., Cranage M., Bergmeier L.A., Mitchell E., Hall G., Dennis M., Cook N., Brookes R., Klavinkis L., Doyle C., Ward R. Protective mucosal immunity elicited by targeted iliac lymph node immunisation with a subunit SIV envelope and core vaccines in macaques. Nat. Med. 2:1996;767-775.
20. + T-cells. Immunol. Today. 17:1996;217-224.
21. Lim S.G., Condez A., Lee C.A., Johnson M.A., Elia C., Poulter L.W. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin. Exp. Immunol. 92:1993;448-454.
22. Lim S.G., Condez A., Poulter L.W. Mucosal macrophage subsets of the gut in HIV: decrease in antigen presenting cell phenotype. Clin. Exp. Immunol. 92:1993;442-447.
23. Marx P.A., Compans R.W., Gettie A., Staas J.K., Gilley R.M., Mulligan M.J., Yamschikov G.V., Chen D., Eldridge J.H. Protection against vaginal SIV transmission with encapsulated vaccine. Science. 260:1993;1323-1327.
24. Miller C.J., McChesney M.B., Lu X., Dailey P.J., Chutkowski C., Brosio P., Roberts B., Lu Y. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from pathogenic vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1997;1191-1921.
25. Montford A.P., Anderson S., Wilson R.A. Induction of Th1 cell mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant. J. Immunol. 156:1996;4739-4745.
26. Pertmer T.M., Roberts T.R., Haynes J.R. Influenza virus nucleoprotein specific immunoglobulin-G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:1996;6119-6125.
27. Ramsay A.J., Leong K.H., Boyle D., Ruby J., Ramshaw I.A. Enhancement of mucosal IgA responses by interleukin-5 and interleukin-6 encoded in recombinant vaccine vectors. Reprod. Fertil. Dev. 6:1994;389-392.
28. Rowland-Jones S.L., Nixon D.F., Aldhous M.C., Gotch F., Ariyoshi K., Hallam N., Kroll J.S., Froebel K., McMichael A. HIV-specific T-cell activity in an HIV-exposed but uninfected infant. Lancet. 341:1993;860-861.
29. Rowland-Jones S.L., Sutton J., Ariyoshi K., Dong T., Gotch F., Mcadam S., Whitby D., Sabally S., Gallimore A., Corrah T., Takiguchi M., Schultz T., McMichael A., Whittle H. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:1995;59-64.
30. Schneider T., Ullrich K., Bergs C., Schmidt W., Riecken E.O., Zeitz M. Abnormalities in subset distribution, activation and differentiation of T-cells isolated from laarge intestine biopsies in HIV infection. Clin. Exp. Immunol. 95:1994;430-435.
31. Smith P.D. Role of the mucosa in human immunodeficiency virus disease. Mucosal Immunol. Update. 2:1994;3-6.
32. Sturgess, C.P., 1997. Studies on mucosal effector mechanisms in feline immunodeficiency virus (FIV) infection in cats. PhD thesis, University of Bristol.
33. Sutjipto S., Pedersen N.C., Miller C.J., Gardner M.B., Hanson C.V., Gettie A., Jennings M., Higgins J., Marx P.A. Inactivated simian immunodeficiency virus-vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J. Virol. 64:1990;2290-2297.
34. Targan S.R., Deem R.L., Liu M., Wang S., Nel A. Definition of a lamina propria T-cell responsive state: enhanced cytokine responsiveness of T-cells stimulated through CD2 pathway. J. Immunol. 154:1995;664-675.
35. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., Dewitt C.M., Friedman A, Hawe L.A., Leander K.R., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
36. + can control HIV infection in vitro by suppressing virus replication. Science. 234:1986;1563-1566.
37. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71:1997;6407-6415.
38. Willett B.J., Hosie M.J., Neil J.C., Turner J.D., Hoxie J.A. Common mechanisms of infection by lentiviruses. Nature. 385:1997;587.
39. Willett B.J., Flynn J.N., Hosie M.J. FIV infection of the domestic cat: an animal model for AIDS. Immunol. Today. 18:1997;182-188.
40. Wilson A.D., Bailey M., Williams N.A., Stokes C.R. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocvanin using cholera toxin as an adjuvant. Eur. J. Immunol. 21:1991;2333-2339.